Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Oliver Y Tang

Showing results (61-70 of 65) with videos related to

Pageof 7
Sort By:
You have reached the last page of results.This site can display upto 65 results.
Nature Communications|March 15, 2018
Atrx inactivation drives disease-defining phenotypes in glioma cells of origin through global epigenomic remodelingCarla Danussi, Promita Bose, Prasanna T Parthasarathy, et al.
Eclinicalmedicine|January 7, 2025
The literacy barrier in clinical trial consents: a retrospective analysisFatima N Mirza, Eric Wu, Hael F Abdulrazeq, et al.
International Journal of Cancer|April 24, 2026
Generation of Allogeneic CAR-T Circumvents Functional Deficits in Patient-Derived Autologous Product for GlioblastomaSabra K Salim, Muhammad Vaseem Shaikh, Jeffrey Wei, et al.
Journal of Neurosurgery|April 18, 2025
AtlasGPT: a language model grounded in neurosurgery with domain-specific data and document retrievalRohaid Ali, Hael F Abdulrazeq, Advait Patil, et al.
Nature Cancer|January 12, 2024
Repeated peripheral infusions of anti-EGFRvIII CAR T cells in combination with pembrolizumab show no efficacy in glioblastoma: a phase 1 trialStephen J Bagley, Zev A Binder, Lamia Lamrani, et al.
Pageof 7

Showing results (61-70 of 65) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 65 results.
Nature Communications|March 15, 2018
Atrx inactivation drives disease-defining phenotypes in glioma cells of origin through global epigenomic remodelingCarla Danussi, Promita Bose, Prasanna T Parthasarathy, et al.
Eclinicalmedicine|January 7, 2025
The literacy barrier in clinical trial consents: a retrospective analysisFatima N Mirza, Eric Wu, Hael F Abdulrazeq, et al.
International Journal of Cancer|April 24, 2026
Generation of Allogeneic CAR-T Circumvents Functional Deficits in Patient-Derived Autologous Product for GlioblastomaSabra K Salim, Muhammad Vaseem Shaikh, Jeffrey Wei, et al.
Journal of Neurosurgery|April 18, 2025
AtlasGPT: a language model grounded in neurosurgery with domain-specific data and document retrievalRohaid Ali, Hael F Abdulrazeq, Advait Patil, et al.
Nature Cancer|January 12, 2024
Repeated peripheral infusions of anti-EGFRvIII CAR T cells in combination with pembrolizumab show no efficacy in glioblastoma: a phase 1 trialStephen J Bagley, Zev A Binder, Lamia Lamrani, et al.
Pageof 7